Biota begins dosing in early stage cold preventative

Fresh from his role as one of the head spruikers of Queensland biotech at BIO in San Diego and DIA in Boston, the CEO of the Queensland Clinical Trials Network, Mario Pennisi, is looking forward to hosting CRX08.

Ethical approval granted for stage II testing of photo-receptive drug

Hagfish may be ferociously ugly little creatures, but they can teach us much about the evolution of the vertebrate eye.

Progen goes into Phase III and ChemGenex Phase II, Bionomics looks at anxiety, Clinuvel gets orphan designation and Avexa announces collaboration and good results.

Embryonic stem cells containing the HOXB4 protein have successfully rebuilt irradiated mice immune systems.

The annual Lorne conferences begin this weekend. First up, protein structure and function, where we learn the tricks of the bacterial toy trade.

Australia's largest biotechnology company, CSL, has released preliminary data on a novel antibody therapy for acute myeloid leukaemia.

Nine of Australia's most renowned scientists have been awarded $4m fellowships by the NHMRC.

Nutrigenomics could be used to help solve the growing obesity crisis.

Clinuvel moves into Phase III for sun intolerance drug earlier than expected.